Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $2,075 | 1 | 73.4% |
| Food and Beverage | $751.35 | 20 | 26.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Ipsen Biopharmaceuticals, Inc | $2,278 | 5 | $0 (2024) |
| Nevro Corp. | $144.71 | 1 | $0 (2023) |
| Allergan Inc. | $127.74 | 7 | $0 (2018) |
| Amgen Inc. | $125.00 | 1 | $0 (2020) |
| Averitas Pharma Inc. | $67.84 | 1 | $0 (2024) |
| Avanir Pharmaceuticals, Inc. | $32.55 | 2 | $0 (2018) |
| Saol Therapeutics Inc. | $26.31 | 2 | $0 (2018) |
| Purdue Pharma L.P. | $13.41 | 1 | $0 (2017) |
| PFIZER INC. | $10.71 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $107.60 | 2 | Averitas Pharma Inc. ($67.84) |
| 2023 | $169.08 | 2 | Nevro Corp. ($144.71) |
| 2021 | $2,196 | 2 | Ipsen Biopharmaceuticals, Inc ($2,196) |
| 2020 | $125.00 | 1 | Amgen Inc. ($125.00) |
| 2018 | $91.27 | 6 | Allergan Inc. ($50.85) |
| 2017 | $137.74 | 8 | Allergan Inc. ($76.89) |
All Payment Transactions
21 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/14/2024 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $67.84 | General |
| Category: PAIN MANAGEMENT | ||||||
| 05/16/2024 | Ipsen Biopharmaceuticals, Inc | Dysport (Drug) | Food and Beverage | In-kind items and services | $39.76 | General |
| Category: Neurology | ||||||
| 07/11/2023 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $144.71 | General |
| Category: Spinal Cord Stimulator | ||||||
| 05/09/2023 | Ipsen Biopharmaceuticals, Inc | Dysport (Drug) | Food and Beverage | In-kind items and services | $24.37 | General |
| Category: Neurology | ||||||
| 07/26/2021 | Ipsen Biopharmaceuticals, Inc | DYSPORT (Drug) | Consulting Fee | Cash or cash equivalent | $2,075.00 | General |
| Category: Neurology | ||||||
| 06/16/2021 | Ipsen Biopharmaceuticals, Inc | DYSPORT (Drug) | Food and Beverage | In-kind items and services | $120.66 | General |
| Category: Neurology | ||||||
| 09/17/2020 | Amgen Inc. | Aimovig (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Neuroscience | ||||||
| 06/08/2018 | PFIZER INC. | LYRICA (Drug), EMBEDA, FLECTOR PATCH | Food and Beverage | In-kind items and services | $10.71 | General |
| Category: NEUROSCIENCE;PAIN | ||||||
| 05/03/2018 | Avanir Pharmaceuticals, Inc. | NUEDEXTA (Drug) | Food and Beverage | In-kind items and services | $15.59 | General |
| Category: pseudobulbar affect (PBA) | ||||||
| 04/19/2018 | Allergan Inc. | BOTOX THERAPEUTIC (Biological) | Food and Beverage | In-kind items and services | $19.80 | General |
| Category: HYPERHYDROSIS | ||||||
| 03/08/2018 | Saol Therapeutics Inc. | Dysport (Drug), Lioresal Intrathecal (baclofen injection) | Food and Beverage | In-kind items and services | $14.12 | General |
| Category: Spasticity | ||||||
| 03/01/2018 | Allergan Inc. | BOTOX THERAPEUTIC (Biological) | Food and Beverage | In-kind items and services | $16.00 | General |
| Category: HYPERHYDROSIS | ||||||
| 02/08/2018 | Allergan Inc. | BOTOX THERAPEUTIC (Biological) | Food and Beverage | In-kind items and services | $15.05 | General |
| Category: HYPERHYDROSIS | ||||||
| 12/21/2017 | Allergan Inc. | BOTOX THERAPEUTIC (Biological) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: HYPERHYDROSIS | ||||||
| 11/02/2017 | Allergan Inc. | BOTOX - SPASTICITY (Drug) | Food and Beverage | In-kind items and services | $20.12 | General |
| Category: SPASTICITY | ||||||
| 10/20/2017 | Saol Therapeutics Inc. | Dysport (Drug), Lioresal Intrathecal | Food and Beverage | In-kind items and services | $12.19 | General |
| Category: Spasticity | ||||||
| 09/28/2017 | Purdue Pharma L.P. | HYSINGLA ER (Drug), OXYCONTIN | Food and Beverage | Cash or cash equivalent | $13.41 | General |
| Category: PAIN MANAGEMENT | ||||||
| 09/13/2017 | Avanir Pharmaceuticals, Inc. | ONZETRA Xsail (Drug) | Food and Beverage | In-kind items and services | $16.96 | General |
| Category: Migraine | ||||||
| 08/17/2017 | Allergan Inc. | BOTOX NEURO REHAB (Drug) | Food and Beverage | In-kind items and services | $19.81 | General |
| Category: NEUROSCIENCE | ||||||
| 06/29/2017 | Ipsen Biopharmaceuticals, Inc | Dysport 300 U-1 (Drug) | Food and Beverage | In-kind items and services | $18.29 | General |
| Category: Neurology | ||||||
| 02/13/2017 | Allergan Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $16.96 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 588 | 961 | $199,058 | $71,937 |
| 2022 | 9 | 542 | 888 | $177,303 | $64,455 |
| 2021 | 9 | 496 | 813 | $220,154 | $61,270 |
| 2020 | 9 | 612 | 1,002 | $157,704 | $78,856 |
All Medicare Procedures & Services
35 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 189 | 503 | $76,959 | $31,350 | 40.7% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 187 | 197 | $57,130 | $19,336 | 33.8% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 66 | 95 | $20,805 | $9,016 | 43.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 23 | 24 | $10,200 | $3,333 | 32.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 31 | 44 | $14,080 | $3,081 | 21.9% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 41 | 41 | $6,273 | $2,628 | 41.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 28 | 34 | $7,378 | $1,765 | 23.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Facility | 2023 | 23 | 23 | $6,233 | $1,427 | 22.9% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 172 | 456 | $67,488 | $26,080 | 38.6% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 156 | 163 | $45,803 | $17,420 | 38.0% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 65 | 106 | $22,472 | $8,756 | 39.0% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 22 | 22 | $9,064 | $3,541 | 39.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 27 | 38 | $11,780 | $2,639 | 22.4% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 37 | 37 | $5,476 | $2,119 | 38.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 28 | 31 | $6,510 | $1,508 | 23.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Facility | 2022 | 24 | 24 | $6,312 | $1,457 | 23.1% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 11 | 11 | $2,398 | $933.78 | 38.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 146 | 399 | $79,849 | $23,464 | 29.4% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 174 | 187 | $73,478 | $20,138 | 27.4% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 48 | 78 | $22,506 | $6,629 | 29.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 31 | 45 | $14,659 | $3,328 | 22.7% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 13 | 13 | $5,484 | $2,144 | 39.1% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Facility | 2021 | 27 | 27 | $8,931 | $1,542 | 17.3% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 25 | 26 | $5,420 | $1,542 | 28.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 20 | 25 | $5,675 | $1,348 | 23.8% |
About Dr. Johnathan Ho, M.D
Dr. Johnathan Ho, M.D is a Physical Medicine & Rehabilitation healthcare provider based in Dearborn, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/05/2011. The National Provider Identifier (NPI) number assigned to this provider is 1710274386.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Johnathan Ho, M.D has received a total of $2,826 in payments from pharmaceutical and medical device companies, with $107.60 received in 2024. These payments were reported across 21 transactions from 9 companies. The most common payment nature is "Consulting Fee" ($2,075).
As a Medicare-enrolled provider, Ho has provided services to 2,238 Medicare beneficiaries, totaling 3,664 services with total Medicare billing of $276,519. Data is available for 4 years (2020–2023), covering 35 distinct procedure/service records.
Practice Information
- Specialty Physical Medicine & Rehabilitation
- Location Dearborn, MI
- Active Since 07/05/2011
- Last Updated 07/18/2015
- Taxonomy Code 208100000X
- Entity Type Individual
- NPI Number 1710274386
Products in Payments
- DYSPORT (Drug) $2,196
- Senza (Device) $144.71
- Aimovig (Biological) $125.00
- Dysport (Drug) $90.44
- BOTOX THERAPEUTIC (Biological) $70.85
- QUTENZA (Drug) $67.84
- BOTOX - SPASTICITY (Drug) $20.12
- BOTOX NEURO REHAB (Drug) $19.81
- Dysport 300 U-1 (Drug) $18.29
- BOTOX (Biological) $16.96
- ONZETRA Xsail (Drug) $16.96
- NUEDEXTA (Drug) $15.59
- HYSINGLA ER (Drug) $13.41
- LYRICA (Drug) $10.71
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physical Medicine & Rehabilitation Doctors in Dearborn
In Yoon, Md, MD
Physical Medicine & Rehabilitation — Payments: $22,463
Eduardo Otero-Loperena, Md, MD
Physical Medicine & Rehabilitation — Payments: $6,822
Luis Torregrosa, Md, MD
Physical Medicine & Rehabilitation — Payments: $5,037
Dr. Riley Smith, M.d, M.D
Physical Medicine & Rehabilitation — Payments: $1,870
Yongmin Liu
Physical Medicine & Rehabilitation — Payments: $1,233
Dr. Sungho Hong, M.d, M.D
Physical Medicine & Rehabilitation — Payments: $1,007